Skip to content
Home/Companies/Biotech/Protera
PR

Protera

Biotech·US·Active·6yr hold

Protera is a software company, headquartered in USA.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Protera?

Protera is currently owned by Sofinnova Partners through Sofinnova Industrial Biotech (2018 vintage), since 2020. Across its history, Protera has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC
2 ownership periods · full history below

Key facts

HQUSA
SectorSoftware

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Pams and Sofinnova Partners since 2020.
Co-invest · 2 holders · 2020 · present
PA
PamsActive
2020 · present · Pamlico Capital · 2013 · Growth
MOIC
–
Sofinnova Partners
Sofinnova PartnersActive
2020 · present · Sofinnova Industrial Biotech · 2018 · VC
MOIC
–

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

Arzeda
Active
BiotechUS· 2022
IB WORKS I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Active
BiotechSpain· 2021
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings